封面
市場調查報告書
商品編碼
2055020

生物材料市場:按材料類型、應用、技術、最終用戶和地區分類

Biomaterials Market, By Material Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials ), By Application, By Technology, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,生物材料市場規模將達到2,415.5億美元,到2033年將達到6,826.6億美元。預計從2026年到2033年,其複合年成長率將達到16.0%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 2415.5億美元
歷史數據時期: 2020-2024 預測期: 2026-2033
2026年至2033年預測期間的複合年成長率: 16.00% 2033年市場規模預測: 6826.6億美元

全球生物材料市場是一個快速擴張的領域,它融合了材料科學、生物技術和醫療保健創新。

生物材料是指種類繁多的天然和合成物質,它們被設計用於與生物系統相互作用,應用於醫療領域,例如植入、藥物傳輸系統、組織工程骨架和診斷設備。這些材料的設計具有生物相容性,並保證在人體內有效發揮作用,且不會引起有害反應。

該市場涵蓋多種類別,包括鈦合金等金屬生物材料、羥基磷灰石等陶瓷生物材料、可生物分解聚合物等聚合物生物材料以及兼具多種性能的複合材料。慢性病日益普遍、全球人口老化、醫療保健成本不斷上漲以及材料科學的持續技術進步,正在推動該領域的顯著成長。

此外,奈米技術、3D列印和智慧材料的融合正在革新生物材料的應用領域,推動個人化和再生醫學的發展。該市場面向廣泛的終端用戶,包括醫院、診所、研究機構和製藥公司,其應用範圍涵蓋整形外科和循環系統植入、傷口護理和組織再生解決方案等。

市場動態

全球生物材料市場受多種關鍵因素驅動,這些因素正在從根本上改變醫療保健的提供方式。其中一個主要成長要素是全球人口的快速老化。隨著老年人關節重建、心血管器械和人工植牙等與老齡化相關的疾病而需要更頻繁的醫療幹預,對醫療植入、義肢和再生醫學解決方案的需求正在顯著成長。

材料科學的進步,包括智慧生物材料、生物活性材料和奈米技術產品的開發,正在擴大應用可能性,並透過增強生物相容性和功能性來改善患者的治療效果。

慢性病、文明病和運動傷害的日益普遍,使得各醫療領域對先進生物材料解決方案的需求顯著成長。然而,該市場面臨許多阻礙因素,可能阻礙其發展。生物材料(尤其是新型材料和應用)複雜而漫長的監管核准流程,構成了市場准入的主要障礙,並延緩了產品的商業化。這需要進行大量的臨床試驗和安全性評估。

除了生物材料高昂的研發和生產成本外,嚴格的品管要求也限制了其應用,尤其是在開發中國家。此外,長期生物相容性、潛在副作用以及複雜的生物相互作用等問題仍然是持續存在的挑戰。儘管有這些限制,再生醫學、組織工程和個人化醫療解決方案等領域新應用的湧現正在創造巨大的市場機會。

本研究的關鍵特徵

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數對全球生物材料市場的主要參與者進行了分析:公司概況、產品系列、主要亮點、財務表現和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 全球生物材料市場報告的目標受群眾外包括行業內的各種相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過分析全球生物材料市場中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 促進因素
  • 抑制因子
  • 機會
  • 影響分析
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景
  • 產業趨勢

第4章 全球生物材料市場:依材料類型分類,2021-2033年

  • 金屬生物材料
  • 以聚合物為基礎的生物材料
  • 陶瓷生物材料
  • 天然生物材料

第5章 全球生物材料市場:依應用領域分類,2021-2033年

  • 整形外科
  • 心血管系統
  • 牙科
  • 整形外科
  • 傷口護理
  • 組織工程
  • 神經病變
  • 眼科
  • 藥物輸送系統

第6章 全球生物材料市場:依技術分類,2021-2033年

  • 3D列印
  • 奈米科技
  • 靜電紡絲
  • 生物列印
  • 水凝膠技術

第7章 全球生物材料市場:依最終用戶分類,2021-2033年

  • 醫院
  • 診所
  • 門診手術中心
  • 研究所
  • 生物技術和製藥公司

第8章 全球生物材料市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第9章 競爭情勢

  • BASF SE
  • Covestro AG
  • Celanese Corporation
  • Carpenter Technology Corporation
  • Royal DSM
  • Evonik Industries AG
  • Berkeley Advanced Biomaterials
  • Cam Bioceramics BV
  • Corbion NV
  • Lubrizol Corporation
  • Zimmer Biomet Holdings Inc
  • Stryker Corporation
  • Johnson and Johnson
  • Medtronic PLC
  • Boston Scientific Corporation

第10章 分析師建議

  • 機會分析
  • 分析師意見
  • 一致的機會地圖

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI8877

Biomaterials Market is estimated to be valued at USD 241.55 Bn in 2026 and is expected to reach USD 682.66 Bn by 2033, growing at a compound annual growth rate (CAGR) of 16.0% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 241.55 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 16.00% 2033 Value Projection: USD 682.66 Bn

The global biomaterials market represents a rapidly expanding sector at the intersection of materials science, biotechnology, and healthcare innovation.

Biomaterials encompass a diverse range of natural and synthetic substances designed to interact with biological systems for medical applications, including implants, drug delivery systems, tissue engineering scaffolds, and diagnostic devices. These materials are engineered to be biocompatible, ensuring they can function effectively within the human body without causing adverse reactions.

The market spans various categories including metallic biomaterials like titanium alloys, ceramic biomaterials such as hydroxyapatite, polymeric biomaterials including biodegradable polymers, and composite materials that combine multiple properties. The increasing prevalence of chronic diseases, aging global population, rising healthcare expenditure, and continuous technological advancements in material science are driving significant growth in this sector.

Moreover, the integration of nanotechnology, 3D printing, and smart materials is revolutionizing biomaterial applications, enabling personalized medicine approaches and regenerative therapies. The market serves diverse end-users including hospitals, clinics, research institutions, and pharmaceutical companies, with applications ranging from orthopedic and cardiovascular implants to wound healing and tissue regeneration solutions.

Market Dynamics

The global biomaterials market is propelled by several key drivers that are fundamentally reshaping the healthcare landscape. The primary growth driver is the rapidly aging global population, which significantly increases the demand for medical implants, prosthetics, and regenerative medicine solutions, as elderly individuals require more frequent medical interventions for age-related conditions such as joint replacements, cardiovascular devices, and dental implants.

Technological advancements in material science, including the development of smart biomaterials, bioactive materials, and nanotechnology-enhanced products, are expanding application possibilities and improving patient outcomes through better biocompatibility and functionality.

The increasing prevalence of chronic diseases, lifestyle-related disorders, and sports injuries is creating substantial demand for advanced biomaterial solutions across various medical specialties. However, the market faces significant restraints that could impede growth trajectories. The complex and lengthy regulatory approval processes for biomaterials, particularly for novel materials and applications, create substantial barriers to market entry and delay product commercialization, requiring extensive clinical trials and safety assessments.

High development and manufacturing costs associated with biomaterials, coupled with stringent quality control requirements, limit accessibility and adoption rates, particularly in developing economies. Additionally, concerns regarding long-term biocompatibility, potential adverse reactions, and the complexity of biological interactions pose ongoing challenges. Despite these restraints, the market presents tremendous opportunities driven by emerging applications in regenerative medicine, tissue engineering, and personalized healthcare solutions..

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global biomaterials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include BASF SE, Covestro AG, Celanese Corporation, Carpenter Technology Corporation, Royal DSM, Evonik Industries AG, Berkeley Advanced Biomaterials, Cam Bioceramics B.V., Corbion N.V., Lubrizol Corporation, Zimmer Biomet Holdings Inc, Stryker Corporation, Johnson and Johnson, Medtronic PLC, and Boston Scientific Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global biomaterials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biomaterials market

Market Segmentation

  • Material Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Metallic Biomaterials
    • Titanium and Titanium Alloys
    • Cobalt-Chrome Alloys
    • Others
  • Polymeric Biomaterials
    • Polymethyl Methacrylate (PMMA)
    • Polyetheretherketone (PEEK)
    • Others
  • Ceramic Biomaterials
    • Calcium Phosphate
    • Zirconia
    • Others
  • Natural Biomaterials
    • Collagen and Gelatin
    • Hyaluronic Acid
    • Others
  • Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Orthopedic
  • Cardiovascular
  • Dental
  • Plastic Surgery
  • Wound Healing
  • Tissue Engineering
  • Neurological Disorders
  • Ophthalmology
  • Drug Delivery Systems
  • Technology Insights (Revenue, USD Bn, 2021 - 2033)
  • 3D Printing
  • Nanotechnology
  • Electrospinning
  • Bioprinting
  • Hydrogels Technology
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Research Laboratories
  • Biotechnology and Pharmaceutical Companies
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • BASF SE
  • Covestro AG
  • Celanese Corporation
  • Carpenter Technology Corporation
  • Royal DSM
  • Evonik Industries AG
  • Berkeley Advanced Biomaterials
  • Cam Bioceramics B.V.
  • Corbion N.V.
  • Lubrizol Corporation
  • Zimmer Biomet Holdings Inc
  • Stryker Corporation
  • Johnson and Johnson
  • Medtronic PLC
  • Boston Scientific Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Biomaterials Market, By Material Type
    • Global Biomaterials Market, By Application
    • Global Biomaterials Market, By Technology
    • Global Biomaterials Market, By End User
    • Global Biomaterials Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Biomaterials Market, By Material Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Metallic Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Titanium and Titanium Alloys
      • Cobalt-Chrome Alloys
      • Others
  • Polymeric Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Polymethyl Methacrylate (PMMA)
      • Polyetheretherketone (PEEK)
      • Others
  • Ceramic Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Calcium Phosphate
      • Zirconia
      • Others
  • Natural Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Collagen and Gelatin
      • Hyaluronic Acid
      • Others

5. Global Biomaterials Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Orthopedic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Dental
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Plastic Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Wound Healing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Tissue Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ophthalmology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Drug Delivery Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Biomaterials Market, By Technology, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • 3D Printing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Nanotechnology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Electrospinning
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Bioprinting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Hydrogels Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Biomaterials Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Biotechnology and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Biomaterials Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • BASF SE
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Covestro AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Celanese Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Carpenter Technology Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Royal DSM
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Evonik Industries AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Berkeley Advanced Biomaterials
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cam Bioceramics B.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Corbion N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lubrizol Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Zimmer Biomet Holdings Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stryker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson and Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us